T cell receptor fusions and conjugates and methods of use thereof

Details for Australian Patent Application No. 2001275246 (hide)

Owner Altor Bioscience Corporation

Inventors Wong, Hing C; Weidanz, Jon A; Card, Kimberlyn F

Agent Pizzeys

Pub. Number AU-B-2001275246

PCT Pub. Number WO01/93913

Priority 60/209,536 05.06.00 US

Filing date 5 June 2001

Wipo publication date 17 December 2001

Acceptance publication date 29 June 2006

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 14/535 (2006.01) Peptides having more than 20 amino acids

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

C07K 14/55 (2006.01) Peptides having more than 20 amino acids

C07K 14/725 (2006.01) Peptides having more than 20 amino acids

Event Publications

27 November 2003 Assignment before Grant

  Sunol Molecular Corporation The application has been assigned to Altor Bioscience Corporation

29 June 2006 Application Accepted

  Published as AU-B-2001275246

26 October 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001275247

2001275245